Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jeng-Yu Jan"'
Autor:
Yu‐Sheng Lin, Jeng‐Yu Jan, Jung‐Jung Chang, Ming‐Shyan Lin, Teng‐Yao Yang, Po‐Chang Wang, Mien‐Cheng Chen
Publikováno v:
ESC Heart Failure, Vol 9, Iss 4, Pp 2548-2557 (2022)
Abstract Aims Ivabradine is indicated for heart failure (HF) patients with reduced ejection fraction (HFrEF), but limited data are available with regards to the use of ivabradine in those with a history of paroxysmal atrial fibrillation (AF). To asse
Externí odkaz:
https://doaj.org/article/fa1a8d43d456455e8f4ed25b8dbbbdd6
Autor:
Teng-Yao Yang, Meng-shu Tsai, Jeng-Yu Jan, Jung-Jung Chang, Chang-Ming Chung, Ming-Shyan Lin, Hui-Ming Chen, Yu-Sheng Lin
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundHeart rate (HR) control is important in heart failure (HF) patients with reduced ejection fraction, and ivabradine is indicated for patients with chronic HF and sinus rhythm. However, ivabradine is limited in initiation of ivabradine at acu
Externí odkaz:
https://doaj.org/article/2a059a0240354f9981613bdbb6231577
Autor:
Mien-Cheng Chen, Ming-Shyan Lin, Teng-Yao Yang, Po-Chang Wang, Jung-Jung Chang, Yu-Sheng Lin, Jeng-Yu Jan
Publikováno v:
SSRN Electronic Journal.
Background: Ivabradine is indicated for heart failure (HF) patients with reduced left ventricular ejection fraction who are in sinus rhythm. However, limited data are available with regards to the use of ivabradine in symptomatic HF patients with red
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f42c2f9d751b74a65ffcc6b2ea43d0af
https://doi.org/10.2139/ssrn.3961382
https://doi.org/10.2139/ssrn.3961382